The restless legs syndrome: Time to recognize a very common movement disorder

Practical Neurology

Volumn 3, Issue 4, 2003, Pages 204-213

  Chaudhuri, K Ray ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APOMORPHINE; BENZODIAZEPINE; CABERGOLINE; CARBAMAZEPINE; CATECHOL METHYLTRANSFERASE; CLONAZEPAM; CLONIDINE; DECARBOXYLASE INHIBITOR; DEXTROPROPOXYPHENE; DIHYDROERGOCRYPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; ENZYME INHIBITOR; GABAPENTIN; LEVODOPA; NALOXONE; NITRAZEPAM; OPIATE; OPIATE ANTAGONIST; ORPHENADRINE; OXYCODONE; PERGOLIDE; PIRIBEDIL; PRAMIPEXOLE; PROPRANOLOL; ROPINIROLE; ROTIGOTINE; TRIAZOLAM; UNINDEXED DRUG;

CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; HUMAN; HYPOTHYROIDISM; INCIDENCE; IRON DEFICIENCY ANEMIA; LIMB MOVEMENT; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PREVALENCE; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SLEEP DISORDER; SYMPTOMATOLOGY; THIRD TRIMESTER PREGNANCY; UREMIA;

EID: 0042566183     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-7766.2003.09160.x     Document Type: Review

References (50)

1. Allen RP, Barker PB, Wehrl F, Song HK & Earley CJ (2001) MRI measurement of brain iron in patients with restless legs syndrome. Neurology, 56, 263-5.
2. Allen RP & Earley CJ (1996) Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep, 19, 205-13.
3. Allen R, Kushida CA, Atkinson MJ & RLS QOL Consortium (2002) Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Medicine, in press.
4. Appiah-Kubi L, Pal S & Chaudhuri KR (2002) Restless legs syndrome (RLS), Parkinson's disease and sustained dopaminergic therapy for RLS. Sleep Medicine, 3, S51-S55.
5. Atlas Task Force of the American Sleep Disorders Association (1993) Recording and scoring of leg movements. Sleep, 16, 748-59.
6. Chaudhuri K, Ray Appiah-Kubi L & Trenkwalder C (2001) Restless legs syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 71, 143-6.
7. Bonati MT, Ferini-Strambi L, Aridon P et al. (2003) Autosominal dominant restless legs syndrome maps on chromosome 149. Brain, 126, 1485-92.
8. Desautels A, Turecki G, Montplaisir J et al. (2001) Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. American Journal of Human Genetics, 69, 1266-70.
9. Earley CJ & Allen RP (1996) Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep Medicine, 3, (Suppl. 1) 523-525.
10. Earley CJ, Connor JR, Beard JL et al. (2000) Abnormalities in CSF concentrations of ferritin and transferring in restless legs syndrome. Neurology, 54, 1698-700.
11. Eisenhsehr I, Wetter TC, Linke R et al. (2001) Normal IPT and IBZM SPECT in drug naïve and levodopa treated idiopathic restless legs syndrome. Neurology, 57, 1307-9.
12. Ekbom KA (1945) Restless Legs Syndrome. Acta Medica Scandinavica, 158, 4-122.
13. Ekbom KA (1960) Restless legs syndrome. Neurology, 10, 868-73.
14. Ferini-Strambi L (2002) Restless legs syndrome augmentation and pramipexole treatment. Sleep Medicine, 3, S23-S25.
15. Garcia-Borreguero D, Larrosa O & de la Llave Y (2002a) Circadian aspects in the pathophysiology of the restless legs syndrome. Sleep Medicine, 3, S17-S21.
16. Garcia-Borreguero D, Larrosa O, Verger K et al. (2002b) Effects of gabapentin on restless legs syndrome. Results of a double blind, crossover study with polysomnographic control on 24 patients. Movement Disorders, 17, S233 (abstract P748).
17. Goodman JDS, Brodie C & Ayida GA (1988) Restless legs syndrome in pregnancy. British Medical Journal, 297, 1101-2.
18. Henning W, Allen R, Earley C, Kushida C, Picchieti D & Silber M (1999) The treatment of restless legs syndrome and periodic limb movement disorder. Sleep, 22, 970-99.
19. Kageyama T, Kabuto M, Nitta H et al. (2000) Prevalences of periodic limb movements of sleep and restless legs syndrome among Japanese adults. Psychiatry and Clinical Neuroscience, 54, 296-8.
20. Lavigne GJ & Montplaisir JY (1994) Restless legs syndrome and sleep bruxism. prevalence and association among Canadians. Sleep, 17, 739-43.
21. Lugaresi E, Coccagna G, Tassinari CA & Ambrosetto C (1965) Polygraphic data on motor phenomena in the restless legs syndrome. Rivista Di Neurologia, 35, 550-61.
22. Mandal S, Appiah-Kubi L, Porter MC & Chaudhuri KR (2002) A clinical observaional study of restless legs syndrome in Parkinson's disease. Movement Disorder, 17, S229.
23. Mathews WB (1976) Iron deficiency and restless legs syndrome. British Medical Journal, 1, 898.
24. Montplaisir J, Boucher S, Poirier G et al. (1997) Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Movement Disorders, 12, 61-5.
25. Montplaisir J, Denesle R & Petit D (2000) Pramipexole in the treatment of restless legs syndrome: a follow up study. European Journal of Neurology, 7, 27-31.
26. Ondo W (2002) Epidemiology of restless legs syndrome. Sleep Medicine, 3, S13-S15.
27. Ondo WG, Vuong K & Jankovic J (2002) Exploring the relationship between Parkinson's disease and restless legs syndrome. Archives Neurology, 59, 421-4.
28. Ondo WG, Vuong KV & Wang Q (2000) Restless legs syndrome in monozygotic twins: clinical correlates. Neurology, 55, 1404-6.
29. Reuter I, Ellis CM & Ray Chaudhuri K (1999) Nocturnal subcutaneous apomorphine infusion in Parkinson's Disease and restless legs syndrome. Acta Neurologica Scandinavica, 100, 163-7.
30. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U & Berger K (2000) Prevalence and risk factors of RLS in an elderly population. The MEMO study. Neurology, 54, 1064-8.
31. Rutkove SB, Matheson JK & Logigian EL (1996) Restless legs syndrome in patients with polyneuropathy. Muscle and Nerve, 19, 670-2.
32. Rye DB (2002) Modulation of normal and pathologic motoneuron activity during sleep. Insights from the neurology clinic, Parkinson's disease, and comments on parkinsonian-related sleepiness. Sleep Medicine, 3, S43-S49.
33. Rye DB & DeLong M (1999) Amelioration of sensory limb discomfort of restless legs syndrome by pallidotomy. Annals Neurology, 46, 800-1.
34. Saletu M, Anderer P, Saletu B et al. (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. Neuropsychobiology, 41, 190-9.
35. Sharif AA (2002) Entacapone in restless legs syndrome. Movement Disorders, 17, 421 (Abstract).
36. Stiasny K, Moller JC, Bodenschartz R et al. (2002) Rotigotine CDS (Constant Delivery System) in the treatment of moderate to advanced stages of restless legs syndrome - a double blind placebo-controlled study. Movement Disorders, 17, S241 (abstract P776).
37. Stiasny K, Robbecke J, Schuler P & Oertel WH (2000b) Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - an open clinical trial. Sleep, 23, 349-54.
38. Stiasny K, Wetter TC, Trenkwalder C & Oertel WH (2000a) Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism and Related Disorders, 7, 21-5.
39. Strang PG (1967) The symptoms of restless legs. Medical Journal of Australia, 1, 1211-3.
40. Tan EK, Seah A, See SJ et al. (2001) Restless legs syndrome in an Asian population: a study in Singapore. Movement Disorders, 16, 577-9.
41. Trenkwalder C, Seidel VC, Gasser T & Oertel WH (1996) Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Movement Disorders, 11, 389-94.
42. Turjanski N, Lees AJ & Brooks DJ (1999) Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology, 52, 932-937.
43. van de Vijver D, Petri H & Sampson T (2002) The epidemiology of diagnosed restless legs syndrome in primary care in the United Kingdom. Movement Disorders, 17, S 243 (abstract P783).
44. Walters AS (1995) Toward a better definition of restless legs syndrome. The International Restless Legs Syndrome Study Group. Movement Disorders, 10, 634-42.
45. Wetter TC, Stiasny K, Winkelmann J et al. (1999) A randomised controlled study of pergolide in patients with restless legs syndrome. Neurology, 52, 944-50.
46. Willis T (1672) De anima brutorum. London: Wells and Scott.
47. Winkelmann J (2002) The genetics of restless legs syndrome. Sleep Medicine, 3, S9-S12.
48. Winkelmann JW, Chertow GM & Lazarus JM (1996) Restless legs syndrome in end stage renal disease. American Journal of Kidney Disease, 28, 372-8.
49. Wittmaak T (1861) Pathologie und Therapie des Sensibilitäts-Neurosen. Lehrbuch der Nervenkrankheiten, Teil 1: Pathologie und Therapie der sensiblen Neurosen. Leipzig: E. Schäfer.
50. Yoakum R (1994) Night walkers: do your legs seem to have a life of their own? Your torment has a name. Modern Maturity, 55, 82-4.